This study is designed to investigate whether APJ receptor acts as a sensor in static pressure-induced cardiomyocyte hypertrophy and to investigate the mechanism of PI3K-autophagy pathway. The left ventricular hypertrophy rat model was established by coarctation of abdominal aorta. H9c2 rat cardiomyocytes were cultured in the presence of static pressure which was given by a custom-made pressure incubator. The results revealed that the expression of apelin/ APJ system, PI3K, Akt and their phosphorylation were significantly increased in the operation group. Static pressure up-regulated the APJ expression, PI3K phosphorylation, Akt phosphorylation, LC3-II/I and beclin-1 expression in cardiomyocytes. APJ shRNA pGPU6/Neo-rat-399, PI3K inhibitor LY294002, Akt inhibitor 1701-1 blocked the up-regulation of APJ, PI3K phosphorylation, Akt phosphorylation, LC3-II/I and beclin-1 expression, respectively. Moreover, static pressure increased the diameter, volume, protein content of cells, and these could be reversed when the cells were treated with pGPU6/Neo-rat-399, LY294002, and autophagy inhibitor 3-methyladenine, respectively. These results suggested that static pressure up-regulates APJ expression to promote cardiomyocyte hypertrophy by a PI3K-autophagy pathway.
Introduction
The APJ (angiotensin II receptor-like 1) receptor is a Gprotein-coupled receptor and its endogenous ligand is apelin [1, 2] . Apelin/APJ system plays an important role in the physiological activities [3] , especially in cardiovascular system [4] [5] [6] [7] . Unexpectedly, APJ receptor was identified to have some functions independent of apelin [8] [9] [10] . Recent studies have demonstrated that except apelin, some secreted peptides, such as Toddler [11] and ELA [12] , may act as the second ligands for APJ in vivo. Moreover, APJ also responds to external stimulus stretch and induces molecular markers of hypertrophy [13, 14] . These studies suggested that APJ may not only be a receptor, but also act as a sensor to respond some external stimulus in myocardial hypertrophy.
Myocardial hypertrophy is a basic adaptive response to the heart for acute and chronic hemodynamic overload [15] . The myocardium response to external stimulus is a critical event in the progression of myocardial hypertrophy [16] . It has been reported that apelin activated APJ signals through Gai, while the stretch activates APJ independent of G-protein and was possibly involved in recruiting b-arrestin [13] . However, it is unknown how APJ responds to external stimulus and the functional role of APJ activated by pressure overload in cardiomyocyte hypertrophy is still poorly understood.
Autophagy is a cellular response to some external stimulus [17] and directly related to the pathological process of clinical diseases [18 -20] , including cardiovascular disease (CVD) [21, 22] , implying that APJ may also be involved in the process of autophagy. Apelin can activate PI3K pathway in vascular smooth muscle cells (VSMCs) [23] and endothelial cells (ECs) [24] , which was reported to be the main signal to regulate autophagy [25, 26] .
Based on these results, we hypothesized that APJ may act as a stress sensor to respond to cardiomyocyte hypertrophy, which was mediated by PI3K-autophagy pathway. This study showed that static pressure (180 mmHg) increases the expression of APJ, activates PI3K pathway, induces cell autophagy, and stimulates the H9c2 cell hypertrophy. Down-regulation of APJ, PI3K inhibitor LY294002 (25 mM), and Akt inhibitor 1701-1 (10 mM) inhibit static pressure-induced cell autophagy and
hypertrophy. Autophagy inhibitor 3-methyladenine (3-MA, 5 mM) blocks static pressure-induced cell hypertrophy.
Materials and Methods
Animal studies All rat experiments in this paper were approved by the local animal care committee and conformed to the Guidance of Humane Care and Use of Laboratory Animals published by the University of South China.
The left ventricular hypertrophy (LVH) rat model was established by coarctation of abdominal aorta. After anesthesia (intraperitoneal injection of 3% pentobarbital solution, 50 mg/kg of body weight), a left laparotomy was performed, the descending aorta was isolated, and a metal clip was placed next to the aorta. The suture was tied around the clip and the aorta at the level of abdominal aorta above the celiac artery. In the sham group, age-matched animals underwent the same procedure without the placement of the aortic clip. The carotis diastolic blood pressure (DBP) and the ratio of heart (milligrams) to body weight (grams) in the eighth week were recorded to assess the success of the LVH rat model. After the model was established, rats were killed and the hearts were taken out to be weighted. The left ventricular myocytes were isolated for western blot analysis or enzymelinked immunosorbent assay (ELISA).
Cell culture and pressure incubator H9c2 rat myocardial cells were obtained from BD1X rat embryos heart tissue [27] and cultured in Dulbecco's modified Eagle's medium (DMEM/high glucose; Hyclone, Logan, USA) supplemented with 10% fetal bovine serum (Gibco, Gaithersburg, USA) at 378C and in a 5% CO 2 humidified atmosphere incubator.
The static pressure was given to H9c2 cells in a custommade pressure incubator [28, 29] . The pressure incubator is a steel container with a door placed in a thermostat oven with a temperature controller. The humidified atmosphere in the container was 5% CO 2 and 95% air. The pressure in the container is controlled by a knob ( pressure controller) between the container and the gas tank to adjust the mixed gas. The pH value of cellular media in the container is monitored by a pH meter.
Enzyme-linked immunosorbent assay
The cells culture fluid was collected in a 1.5 ml microcentrifuge tube from the 24-well cell culture plates. After being centrifuged at 950 g for 30 min, the supernatant was collected and the level of apelin in supernatants was detected by the rat apelin-13 ELISA kit according to the manufacturer's protocol (Phoenix Biotech, Phoenix, USA). Briefly, the standard and samples (50 ml) were pipetted into appropriate wells and incubated 30 min at room temperature (RT). Then the plates were washed with washing buffer and incubated with 50 ml/well streptavidin-horseradish peroxidase (SA-HRP) for 30 min at RT in the dark. Then the plates were washed again. Finally, 100 ml of stop solution (2 M HCl) was added into each well, and the absorbance was measured at 450 nm using a MicroPlate Reader (BioTek, Seattle, USA).
The short hairpin RNA plasmid transfection The short hairpin RNAs (shRNAs) were designed according to the database sequences and synthesized by GenePharma Co., Ltd (Shanghai, China) ( Table 1) . Four distinct, sequence-specific shRNAs targeting APJ mRNA and a negative shRNA were designed and cloned into pGPU6/Neo vector ( pGPU6/Neo-rat-531; pGPU6/Neo-rat-759; pGPU6/ Neo-rat-1071; pGPU6/Neo-rat-399; pGPU6/neo-shNC). Then, they were transfected into the cells using Attractene Transfection Reagent (Qiagen, Hilden, Germany) according to the manufacturer's instruction. One of the shRNA was chosen for further experiments according to the RNA interference efficiency test. Western blot analysis Cells were washed twice with ice-cold phosphate-buffered saline (PBS) and lysed in a HEPES buffer (20 mM, pH 7.4).
After being centrifuged at 14000 g for 30 min, the supernatant was collected, and the protein concentrations were determined using a bicinchoninic acid (BCA) protein assay kit (Hyclone). Aliquots containing 30 mg of protein were electrophoresed in 10% sodium dodecyl sulfate -polyacrylamide gels and transferred onto polyvinylidene difluoride membranes. Membranes were blocked in milk for 2 h at RT. The proteins were analyzed with the following primary antibodies: anti-PI3K, anti-p-PI3K, anti-Akt, and anti-p-Akt. The membranes were incubated with the primary antibody diluted in blocking solution for 2 h and washed by Trisbuffered saline for three times; and then incubated with the corresponding secondary antibody, HRP-conjugated antirabbit, or anti-goat IgG. The quantity of protein was detected by enhanced chemiluminescence and analyzed by densitometry using a densitometer and an imager.
Cardiomyocyte hypertrophy detection
In the six-well cell culture plates, 1 Â 10 4 cells per well were seeded. After drug treatment, cells were digested and collected by a centrifugation at 100 g for 5 min. Then, PBS was used to dilute the single-cell suspension with an appropriate diluent so that the cell concentration is 5 Â 10 4 -1 Â 10 5 cells/ml in a 2 ml microcentrifuge tube. The diameter and volume of H9c2 rat cardiomyocytes were detected by Scepter TM Handheld Automated Cell Counter (Millipore, Billerica, USA), and the protein content was measured by using a BCA protein assay kit.
Statistical analysis
All data are presented as the mean + SD of the indicated number of measurements. The one-way analysis of variance test was used to determine the significance, with P , 0.05 and P , 0.01 as the cutoff for statistical significance.
Results
The apelin/APJ system, PI3K, Akt are over-expressed in the LVH Sprague-Dawley rat models To establish the LVH Sprague-Dawley (SD) models, we performed a laparotomy and put a silver clip to grip the abdominal aorta. In the operation group, the carotis DBP (Fig. 1A) and the ratio of heart (mg) to body weight (g) (Fig. 1B) were significantly increased compared with those in the sham group. ELISA and western blot analysis of extracts prepared from the isolated left ventricular myocytes showed that the levels of apelin (Fig. 1C) , and APJ (Fig. 1D) are elevated, and the degradation enzyme angiotensin-converting enzyme 2 is decreased (Fig. 1E) . In addition, the levels of PI3K and Akt were up-regulated and their phosphorylations were increased in the operation group, which was possibly regulated by APJ in cardiovascular system (Fig. 1F) [23] .
Static pressure promotes cardiomyocyte hypertrophy by APJ receptor It has been reported that APJ-KO mice are protected from hypertrophy after transaortic constriction [13] . We hypothesized that APJ occupied a pivotal point linking sustained overload to cardiomyocyte hypertrophy. To follow this hypothesis, we treated H9c2 rat cardiomyocytes with static pressure (180 mmHg) for 48 h. Static pressure increases the diameter, the volume, and the protein content of cells, and APJ shRNA blocks the increase of cell diameter, volume, and protein content induced by static pressure ( Table 2) . These results suggested that APJ regulates cardiomyocyte hypertrophy induced by static pressure.
To determine whether APJ modulates cardiomyocytes response to pressure stimulation, different contents of static pressure (0, 60, 90, 120, 150, and 180 mmHg) were used to stimulate cells for 48 h. Results from western blot analysis suggested that the expression of APJ is increased, with significant expression at 180 mmHg ( Fig. 2A) . When static pressure (180 mmHg) was given to cells at different timepoints (0, 6, 12, 24, and 48 h), the expression of APJ was also increased (Fig. 2B) . Together, these data demonstrated that APJ responds to static pressure in cardiomyocyte hypertrophy.
Static pressure activates PI3K pathway PI3K/Akt pathway is a crucial signal pathway in many aspects of cell growth, survival, apoptosis and also involved in some processes of the pathology [30] , such as myocardial hypertrophy [31, 32] . We have reported that apelin could activate PI3K/Akt pathway by APJ receptor, and promoted VSMC proliferation [23] , EC adhesion [33] . As already mentioned above that the expression of PI3K, Akt and their phosphorylation are all increased in LVH left ventricular myocytes, however, it is unknown whether PI3K/Akt pathway is activated by pressure. To identify if static pressure activates PI3K/Akt pathway in cardiomyocytes, cells are simulated by static pressure (180 mmHg) for 30 min. Western blot results showed that there is no change in the expression of PI3K and Akt (Fig. 3A-C) , whereas the levels of PI3K and Akt phosphorylation were increased in static pressuresimulated cells compared with non-treated cells (Fig. 3D) . All these data suggested that static pressure activates PI3K/Akt pathway in cardiomyocytes.
Static pressure induces autophagy through PI3K pathway
To test if APJ is involved in autophagy under the pressure condition, we used different static pressures (0, 60, 90, 120, 150, and 180 mmHg) to simulate cells for 48 h, and western blot analysis showed that static pressure increased the APJ response to static pressure in cardiomyocyte hypertrophy expression of LC3-II/I and beclin-1, with significant expression at 180 mmHg (Fig. 4A) . When cells were simulated under static pressure (180 mmHg) for different timepoints (0, 3, 6, 12, and 24 h), the levels of LC3-II/I and beclin-1 were also increased (Fig. 4B) . We designed four shRNAs to interfere APJ, and found that pGPU6/Neo-rat-399 had the best interference efficiency (data not shown). The increased expressions of LC3-II/I and beclin-1 were significantly blocked when cells were treated with pGPU6/Neo-rat-399 to interfere the expression of APJ (Fig. 4C) . All these results showed that static pressure (180 mmHg) induced H9c2 cell autophagy by APJ.
The regulation of autophagy is very complex and the PI3K/Akt pathway and mTOR/p70S6K pathway are the two main pathways to regulate autophagy [34] . To illustrate that PI3K/Akt pathway also regulates cardiomyocyte autophagy The apelin/APJ system and the expression of PI3K, Akt are increased in the LVH models The LVH SD model is established by using a metal clip placed next to the aorta. The arteria carotis DBP (A) and the ratio of body weight to heart weight (B) are increased in the operation group. The level of apelin-13 in heart tissue is increased in the operation group (C). Western blot results showed that the expression of APJ in heart tissue is up-regulated (D) and the ACE2 is decreased (E). The expression levels of PI3K and Akt are up-regulated and their phosphorylation are also increased (F). Data are shown as the mean + SD. n ¼ 7. *P , 0.05; **P , 0.01 vs. sham group.
APJ response to static pressure in cardiomyocyte hypertrophy
induced by static pressure, we pre-incubated cells with the specific PI3K inhibitor LY294002 or specific Akt inhibitor 1701-1 for 30 min, then applied static pressure (180 mmHg) for 48 h. Results showed that LY294002 and 1701-1 significantly blocked the increase of LC3-II/I and beclin-1 induced by static pressure (180 mmHg) (Fig. 4D) . These data showed that PI3K/Akt regulated cardiomyocyte autophagy induced by static pressure.
PI3K autophagy is involved in the cardiomyocytes hypertrophy induced by static pressure Autophagy has been linked to CVD, especially in cardiac hypertrophy. PI3K/Akt pathway not only regulates autophagy, but also influences cardiac hypertrophy. To test if PI3K autophagy is involved in the process of cardiomyocytes hypertrophy, we used specific PI3K inhibitor LY294002 (25 mM), Akt inhibitor 1701-1 (10 mM), and APJ response to static pressure in cardiomyocyte hypertrophy autophagy inhibitor 3-MA (10 mM) to stimulate cells, and found that LY294002, 1701-1, and 3-MA reversed the increase of cell diameter, volume, protein content induced by static pressure ( Table 3 ). These data suggested that static pressure promoted cardiomyocyte hypertrophy by activating PI3K and inducing autophagy.
Discussion
Myocardial hypertrophy is a basic adaptive response to the heart for acute and chronic hemodynamic overload [35] , with the main features of increased protein synthesis in the cell and increased size of the cell [36] . And the critical process of myocardial hypertrophy is the cardiac response to pressure overload [16] . The results presented in this study demonstrated for the first time that the cardiac responses to static pressure by APJ membrane receptor. We further identified that intracellular PI3K signal pathway is involved in the process of cardiac response to static pressure. In addition, we showed that APJ shRNA and PI3K inhibitor LY294002 reverse the cells autophagy induced by static pressure. Finally, we demonstrated that PI3K-autophagy pathway regulates cardiomyocytes in response to static pressure. We proposed that APJ membrane receptor transforms the external stimuli to intracellular PI3K signal, induces autophagy, and promotes cardiomyocytes hypertrophy. The relationships are summarized in Fig. 5 . APJ response to static pressure in cardiomyocyte hypertrophy A significant finding in this study is that APJ receptor plays a crucial role in modulating cardiac responding to pathological pressure load. Our results showed that the expression of APJ was increased when cells were treated with static pressure. Static pressure increased the diameter, volume, and protein content of cells, while an attenuated cardiomyopathic response was observed when cells were treated with shRNA-APJ. Overall, these data suggested that APJ acts as a membrane receptor, is sensitive to pressure overload stimulation, regulates signal transduction in the cells, and leads to cell hypertrophy. However, the mechanism for the cardiomyocyte respond to pressure overload is still unknown. Further studies are needed to explore the mechanisms by which APJ functions in cardiomyocytes responding to pressure overload.
Our observations demonstrated that the cardiac responds to pressure overload by APJ receptor and adds an important new piece of information revealing that APJ also plays a crucial role in modulating cardiac responding to autophagy induced by pressure overload, which has not been reported. Autophagy is a process by which cell recycle cytoplasm and defective organelles during stress situations such as nutrient starvation. APJ response to static pressure in cardiomyocyte hypertrophy In the heart, the level of autophagy is altered not only in response to stress such as ischemia/reperfusion [37] [38] [39] , but also to stress triggered by CVDs such as cardiac hypertrophy [40] and heart failure [41, 42] . Our results showed that static pressure induced the expression of autophagy markers LC3-II/ I and beclin-1, and APJ shRNA blocked the increase of LC3-II/I and beclin-1 induced by static pressure. Some different observations have been reported that apelin decreases cell autophagy induced by hypoxic [43] or glucose deprivation [44] . They described that apelin decreases autophagy induced by hypoxia, while has no effect on autophagy without hypoxia in pulmonary artery smooth muscle cells. These results have some contradictions with the activation of PI3K/Akt/mTOR pathway induced by apelin without hypoxia. Apelin inhibited glucose deprivation-induced cardiomyocyte autophagy, but authors did not use RNAi to confirm the effect. With the use of APJ shRNA, our study showed that static pressure induced cardiomyocyte autophagy by activation of APJ. There are some different effects between apelin and stress on the activation of APJ in myocardial hypertrophy [13] . They may also have different effects on the cardiomyocyte autophagy. Besides, there are also some reports showing that apelin increases autophagy [20, 45] . So it is possible that pressure induces autophagy by APJ. PI3K/Akt pathway is a main pathway in cell signal transduction which is involved in the process of cardiac hypertrophy [46, 47] . Our results showed that PI3K/Akt pathway regulates myocardial hypertrophy and autophagy induced by static pressure. We also found that the PI3K phosphorylation and Akt phosphorylation are up-regulated in LVH myocardial tissue and static pressure-treated cells. LY294002 and 1701-1 reversed cell hypertrophy induced by static pressure. LY294002 and 1701-1 blocked the increase of LC3-II/I and beclin-1 induced by static pressure. All these data illustrated that PI3K/Akt pathway regulates cell autophagy and hypertrophy induced by static pressure. But it is interesting to note that the expression of PI3K is increased in the LVH myocardial tissue, but does not change in the static pressure-treated cells. Further studies are needed to explain the difference between static pressure-treated cells and the LVH models.
There are important implications of these findings for pressure overload in CVD, especially in myocardial hypertrophy. We identified that, without APJ receptor, heart tissue could not respond to pressure overload, which lead to some target organ damages. Pressure load may act as an important risk factor in myocardial hypertrophy for patient. The APJ may become a new target for myocardial hypertrophy because of its functions in cardiomyocytes responding to pressure overload.
Angiotensin-converting enzyme inhibitor (ACEi), CCB, statins, and b-blockers have been used as drugs to reduce the pressure overload in clinic. It has been reported that apelin is degraded by ACE2 and apelin affects the functions of Ang II [48, 49] . Puerarin affects CCB to regulate blood pressure through apelin/APJ pathway [50] . Statin regulates APJ expression and disturbs gene function of endothelial targets [51] . So our results may provide a new mechanism to explain the function of drugs (ACEi, CCB, and statins) in CVDs treatment.
We need to highlight some limitations of this study. First of all, this analysis has been performed in a custom-made pressure incubator and H9c2 rat myocardial cells are obtained from BD1X rat embryos heart tissue, which is quite different from the LVH models and patients. The static pressure is given by a custom-made pressure incubator using mixed gas in the airtight container, while in the LVH model, the heart tissue in a state of complex situation (not only simulated by a pressure, but also by hypoxia, ischemia, and so on). In addition, we did not demonstrate the effect of pGPU6/Neo-rat-399, LY294002, or 3-MA in vivo, which may have the potential impact for future therapeutic interventions. Moreover, we did not test the patients who have LVH. So our results only reflected the basic mechanism in cells, which needs to be confirmed by further clinical studies. In addition, the expression of beclin-1 and LC3-II/I cannot exactly reflect the process of autophagy, so more markers are needed to determine the level of autophagy.
In summary, we provided the evidence that APJ receptor acts as a pressure sensor to promote H9c2 rat cardiomyocyte hypertrophy. And the mechanism may be that APJ transforms the static pressure simulation to a PI3K-autophagy signal pathway.
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